The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors.

Hannah C TimminsTiffany LiDavid GoldsteinTerry TrinhDavid MizrahiMichelle HarrisonLisa G HorvathMichael FriedlanderMatthew C KiernanSusanna B Park

Published in: Journal of cancer survivorship : research and practice (2021)

Identifying routinely measured patient characteristics which may contribute to an individual's CIPN risk profile could assist with informing treatment decisions.